July 20, 2018 — CP3 Director Walid Gellad weighs in on Merck's measures for lowering drug prices. In this LA Times article, Dr. Gellad notes, "What Merck did was not of much benefit at all. In fact, it’s counterproductive if the industry is saying it wants to help but really is just pretending." Read More »